BridgeBio Pharma CEO Neil Kumar's 2019 pay jumps 6,298% to $26M
BridgeBio Pharma reports 2019 executive compensation
By ExecPay News
Published: April 22, 2020
BridgeBio Pharma reported fiscal year 2019 executive compensation information on April 22, 2020.
In 2019, three executives at BridgeBio Pharma received on average a compensation package of $13M, a 2,897% increase compared to previous year.
Average pay of disclosed executives at BridgeBio Pharma
Neil Kumar, Chief Executive Officer, received $26M in total, which increased by 5,752% compared to 2018. 53% of Kumar's compensation, or $14M, was in stock awards. Kumar also received $360K in bonus, $12M in option awards, $503K in salary, as well as $35K in other compensation.
Brian Stolz, Chief Operating Officer, received a compensation package of $8.1M. 84% of the compensation package, or $6.9M, was in stock awards.
Charles Homcy, Chairman, earned $6M in 2019.
Related executives
You may also like
Source: SEC filing on April 22, 2020.